Nick attended the University of Massachusetts Amherst and received a BS in Biochemistry & Molecular Biology and a BA in Spanish. At UMass, he developed an interest in research by using molecular biology techniques to elucidate signal transduction pathways in Arabidopsis thaliana. At DFCI, Nick worked on optimizing MDM2 inhibition in a window of opportunity trial in GBM, and studied gene dosage compensation mechanisms in amplification-related events pan-cancer. Nick is currently pursuing an MD at the University of Miami Miller School of Medicine.